Earnings Preview: SH PHARMA to Report Financial Results on April 29

Moomoo News13:45 ET

Shanghai Pharmaceutical Group Co., Ltd. Report for the first quarter of 2025

SZSI12:00 ET · Announcements

Shanghai Pharmaceuticals' Q1 Profit Slides 14%

MT NewswiresApr 28 09:05 ET

Express News | Shanghai Pharmaceuticals - Qtrly Net Profit Attributable RMB1.33 Bln

ReutersApr 28 05:01 ET

SH PHARMA: 2025 FIRST QUARTERLY REPORT

HKEXApr 28 05:00 ET · Announcements

SH PHARMA (601607.SH): In the first quarter, Net income was 1.333 billion yuan, a year-on-year decrease of 13.56%.

Gelonghui, on April 28, reported that SH PHARMA (601607.SH) announced its first quarter report for 2025, achieving revenue of 70.763 billion yuan, a year-on-year increase of 0.87%; Net income attributable to shareholders of the listed company was 1.333 billion yuan, a year-on-year decrease of 13.56%; EPS was 0.36 yuan.

Gelonghui FinanceApr 28 03:38 ET